XWELL, Inc. Share Price

XWEL

US98420U8027

Personal Services

Market Closed - Nasdaq 21:30:00 11/09/2026 BST			5-day change	1st Jan Change
0.9647 ^USD	+2.34%		-1.11%	+109.35%

08-14	XWELL, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-05	XWELL, Inc. Announces Board and Committee Changes, Effective August 8, 2026	CI

Last Transcript: XWELL, Inc.

XWELL, Inc., Q2 2025 Earnings Call, Aug 14, 2025

15/08/25

More transcripts

Analysts' recommendations: XWELL, Inc.

04/04/23	HC Wainwright Trims XWELL's Price Target to $1 From $1.50, Keeps Buy Rating	MT
16/11/22	HC Wainwright Adjusts Price Target on XWELL to $1.50 From $2, Maintains Buy Rating	MT
18/05/22	HC Wainwright Adjusts Price Target on XpresSpa Group to $2 From $4, Reiterates Buy Rating	MT
17/11/21	HC Wainwright Adjusts Price Target on XpresSpa Group to $4 From $3.50, Reiterates Buy Rating	MT
16/02/21	XpresSpa : HC Wainwright Starts XpresSpa Group at Buy With $3.50 Price Target	MT

More recommendations

News in other languages: XWELL, Inc.

30/09/20

Morning Briefing - International

More news

Managers and Directors: XWELL, Inc.

Manager	Title	Age	Since
Ezra Ernst CEO	Chief Executive Officer	57	03/09/2024
Thomas Brown DFI	Director of Finance/CFO	57	05/01/2025
Patti Ward COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Bruce Bernstein CHM	Chairman	62	31/01/2018
Robert Weinstein BRD	Director/Board Member	66	02/02/2020
Michael Lebowitz BRD	Director/Board Member	54	06/04/2020

More insiders

XWELL, Inc. is a global wellness company. The Company delivers restorative and health-focused services to travelers through its three operating segments: XpresSpa, XpresTest, and Naples Wax Center. XpresSpa operates spa service locations in major airports, offering massage, skincare, and travel products. The XpresTest segment provides aircraft wastewater and passenger nasal sampling through the Centers for Disease Control and Prevention's (CDC's) bio-surveillance program. The Naples Wax Center segment operates six locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products. Its health wellness beauty services include massage, waxing, facials, stretch, light emitting diode (LED) light therapy, meditation, manicures, pedicures, aromatherapy, anti-aging treatments, compression therapy, and massage chairs. Its subsidiaries include Naples Wax FRM LLC, Quantum Stream Inc., XpresSpa Holdings, LLC, XpresTest, Inc., and others.

Employees

228

Sector

Personal Services

More about the company

Quotes

Date	Price	Change	Volume
11/09/26	US$0.9647	+2.34%	5,440
10/09/26	US$0.9426	+1.31%	26,755
09/09/26	US$0.9305	-2.83%	76,465
08/09/26	US$0.9575	-1.85%	26,851

Delayed Quote Nasdaq

More quotes

Market Cap	8.29M 7.14M 6.76M 6.13M 11.5M 792M 11.55M 80.29M 30.87M 403M 31.12M 30.44M 1.27B	P/E 2024	-0.41x	P/E 2025	-0.09x
Enterprise Value	18.15M 15.64M 14.81M 13.42M 25.18M 1.73B 25.31M 176M 67.62M 882M 68.16M 66.67M 2.79B	EV / Sales 2024	0.2x	EV / Sales 2025	0.43x
Free-Float	72.89%	Yield 2024 *	-	Yield 2025	-

08-14	XWELL, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-05	XWELL, Inc. Announces Board and Committee Changes, Effective August 8, 2026	CI
07-07	Xwell Agrees to Sell XpresSpa, XpresTest Businesses for $13 Million	MT
07-06	Face Haus, LLC entered into a definitive agreement to acquire Xprestest Inc. and XpresSpa Holdings, LLC from XWELL, Inc. for $13 million.	CI
05-20	XWELL, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-01	Xwell registers resale of up to 138.7 million shares of common stock from time to time by selling stockholders - SEC filing	RE
04-01	XWELL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-24	Xwell announces approximately $31.3 million private placement priced at the market under Nasdaq rules	RE
02-23	XWELL, Inc. announced that it expects to receive $31.333 million in funding	CI
02-03	XWELL Inc. and PieQ Advance AI-Powered Biosecurity Forecasting Following CDC Milestone	CI
01-08	Xwell, Inc. Appoints Cindy Friedman as Senior Advisor	CI
12-18	XWELL Expands Beyond Airports with New Wellness Retail Location in New York City's Pennsylvania Station	CI
11-14	Wellness services firm XWELL's Q3 operating loss narrows	RE

08-05	XWELL Appoints Global Energy and Capital Markets Leader Gerard Reid to its Board of Directors	AQ
07-07	XWELL Announces Definitive Agreement to Divest XpresSpa and XpresTest Businesses	AQ
04-01	XWELL Reports Fiscal 2025 Results	AQ
02-27	Nasdaq Small-Caps: SNYR, XWEL, FGL, FMFC, Surge Into 2026 Spotlight	AQ
02-24	XWELL : Announces Approximately $31.3 Million Private Placement Priced At The Market Under Nasdaq Rules	PU

1 day	+2.34%
1 week	-1.11%
Current month	+5.70%
1 month	-4.49%
3 months	-20.27%
6 months	-38.94%
Current year	+109.35%

1 week	0.92	0.99
1 month	0.87	1.17
Current year	0.26	2.2
1 year	0.26	2.2
3 years	0.26	3.8
5 years	0.26	43.8
10 years	0.26	4,860

XWELL, Inc. Share Price

Stocks

XWEL

US98420U8027

Personal Services

Valuation: XWELL, Inc.

Chart: XWELL, Inc.

Latest news: XWELL, Inc.

Last Transcript: XWELL, Inc.

Analysts' recommendations: XWELL, Inc.

Press Releases: XWELL, Inc.

News in other languages: XWELL, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: XWELL, Inc.

Latest insider transactions

Personal Care Services

Financials

Company Profile

Quotes

Date	Insider	Type	Main position	Quantity	% Market Cap.
25/08/26	Gaëlle Wizenberg	Free	Director	50,000	0.5821%
25/08/26	Michael Lebowitz	Free	Director	50,000	0.5821%
25/08/26	Robert Weinstein	Free	Director	50,000	0.5821%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
XWELL, INC.	+2.34%	-1.11%	-12.30%	-73.41%	8.29M
FAMEGLOW HOLDINGS LIMITED	+10.70%	+5.00%	+965.99%	+2,943.48%	1.98B
BEAUTY FARM MEDICAL AND HEALTH INDUSTRY INC.	+2.28%	+4.43%	-52.26%	+57.72%	569M
CONVANO INC.	+2.70%	-5.00%	-51.69%	+1,448.91%	360M
SKINKANDY LIMITED	-5.00%	+6.83%	-	-	224M
PERFECT MEDICAL HEALTH MANAGEMENT LIMITED	-2.69%	-2.69%	-18.39%	-67.40%	208M
AB&COMPANY CO.,LTD.	+0.33%	-1.63%	+51.20%	+22.33%	140M
SIAM WELLNESS GROUP	-0.66%	0.00%	-8.54%	-66.17%	117M
QB NET HOLDINGS CO.,LTD.	+0.95%	-1.63%	-5.86%	-21.07%	111M
EC HEALTHCARE	0.00%	+18.60%	-33.77%	-83.96%	77.07M
Average	+1.10%	-1.00%	+92.71%	+462.27%	379.52M
Weighted average by Cap.	+5.76%	-9.93%	+522.00%	+1,780.30%

	2024	2025
Net sales	33.9M 29.21M 27.65M 25.07M 47.02M 3.24B 47.26M 328M 126M 1.65B 127M 125M 5.21B	29.21M 25.17M 23.83M 21.6M 40.52M 2.79B 40.73M 283M 109M 1.42B 110M 107M 4.49B
Net income	-16.85M -14.52M -13.75M -12.46M -23.38M -1.61B -23.5M -163M -62.79M -819M -63.29M -61.9M -2.59B	-16.99M -14.64M -13.86M -12.56M -23.57M -1.62B -23.69M -165M -63.31M -826M -63.81M -62.41M -2.61B
Net Debt	-1.03M -887K -840K -762K -1.43M -98.4M -1.44M -9.98M -3.84M -50.06M -3.87M -3.78M -158M	9.86M 8.5M 8.05M 7.29M 13.68M 942M 13.75M 95.57M 36.75M 479M 37.04M 36.23M 1.51B